Skip to main content
Continental Chemicals Ltd. logo

Continental Chemicals Ltd. — Investor Relations & Filings

Ticker · 506935 ISIN · INE423K01015 BSE.NS Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2020-10-17 Regulatory Filings
Country IN India
Listing BSE.NS 506935

About Continental Chemicals Ltd.

https://www.continentalchemicalsltd.com/

Continental Chemicals Ltd. specializes in the manufacturing and marketing of soaps, detergents, and personal care products. The company’s core operations involve the production of a diverse range of cleaning agents, including laundry soaps, detergent powders, and liquid detergents. Its product portfolio also encompasses toilet soaps and specialized hygiene solutions tailored for household and institutional applications. Established with a focus on formulation quality and product efficacy, the organization leverages its extensive experience to provide essential sanitation and cleaning goods. The company maintains a commitment to consistent product standards and distribution efficiency, catering to broad consumer needs for hygiene and maintenance products.

Recent filings

Filing Released Lang Actions
Compliances-Reg. 40(10)- PCS Certificate for Transfer/Transmission/Transposition
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 30th September 2020. It certifies the timely issuance of share certificates related to share transfers during the period. The document is a compliance certificate related to share transfer processes, not a financial report or announcement of financial results. It is a regulatory compliance filing related to share transfer documentation and does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains the certificate text itself. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other categories.
2020-10-17 English
Reg. 7(3) Compliance Certificate
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 30.09.2020. It is signed by the Registrar and Share Transfer Agent and the Managing Director. The document confirms compliance activities related to share transfer facilities. It does not contain financial statements or substantive financial data, nor is it a report itself. It is a regulatory compliance certificate submitted to the stock exchange. The document length is short (2367 characters) and it is a certificate rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance certificate filing.
2020-10-09 English
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Share Transfer Agent. It confirms compliance related to dematerialization of securities for the quarter ended September 2020. The document is a regulatory compliance certificate, not a financial report or announcement of financial results. It is short (2523 characters) and serves as a formal confirmation letter to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance-related filing that does not fit other specific categories.
2020-10-09 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notification to the Bombay Stock Exchange about the closure of the trading window for insiders due to upcoming financial results for the quarter ended 30th September 2020. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The document does not contain any financial data, results, or detailed report but is an announcement related to trading restrictions ahead of financial disclosures. It is a regulatory announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement, not a report itself.
2020-10-01 English
With reference to captioned subject, we wish to inform you that the Company has extended its Annual General Meeting ("AGM") for the Financial Year 2019-20, as per provisions of the ....
AGM Information Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange informing about the extension of the Annual General Meeting (AGM) for the financial year 2019-20. It references regulatory provisions and an order from the Registrar of Companies. The document does not contain the AGM materials or minutes but is an announcement related to the scheduling of the AGM. The document length is short (972 characters), and it serves as a notification rather than the AGM report or presentation itself. Therefore, it fits best under AGM Information (AGM-R) as it relates to the AGM event and its scheduling information.
2020-09-14 English
Pursuant to regulation 32 of regulation 32 of SEBI(LODR) Regulations, 2015, please find attached Statement of deviation and variation of utilization of fund raised through preferential issue.
Regulatory Filings Classification · 95% confidence The document is a Statement of Deviation under Regulation 32 of SEBI (LODR) Regulations, 2015, concerning the utilization of funds raised through a preferential issue. It is addressed to the Bombay Stock Exchange and includes details about the fund raising, amount raised, and confirmation that there is no deviation in the use of funds. The document is a regulatory compliance filing related to fund utilization and does not contain financial statements or detailed financial performance data. It is not an annual or interim report, nor an earnings release or management discussion. It is a specific regulatory filing required by SEBI for disclosure of fund usage deviations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-09-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.